{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:58:18Z","timestamp":1768294698828,"version":"3.49.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.neuropharm.2011.04.015","type":"journal-article","created":{"date-parts":[[2011,4,25]],"date-time":"2011-04-25T04:57:07Z","timestamp":1303707427000},"page":"283-292","source":"Crossref","is-referenced-by-count":31,"title":["Methylphenidate and \u03bc opioid receptor interactions: A pharmacological target for prevention of stimulant abuse"],"prefix":"10.1016","volume":"61","author":[{"given":"Jinmin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee-Yuan","family":"Liu-Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Biederman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep G.","family":"Bhide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.04.015_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000159776","article-title":"Disposition of naltrexone after intravenous bolus administration in Wistar rats, low-alcohol-drinking rats and high-alcohol-drinking rats","volume":"58","author":"Akala","year":"2008","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ar.a.20054","article-title":"Ultrastructural evidence for co-localization of dopamine D2 and micro-opioid receptors in the rat dorsolateral striatum","volume":"279","author":"Ambrose","year":"2004","journal-title":"Anat. Rec. A Discov. Mol. Cell Evol. Biol."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nn777","article-title":"Altered responsiveness to cocaine in rats exposed to methylphenidate during development","volume":"5","author":"Andersen","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib4","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1038\/sj.npp.1301164","article-title":"Stimulants: therapeutic actions in ADHD","volume":"31","author":"Arnsten","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1098-2396(199810)30:2<181::AID-SYN8>3.0.CO;2-8","article-title":"Effects of intraaccumbens administration of SCH-23390 on cocaine-induced locomotion and conditioned place preference","volume":"30","author":"Baker","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0022-3565(25)20979-X","article-title":"Differential effects of intra-accumbens sulpiride on cocaine-induced locomotion and conditioned place preference","volume":"279","author":"Baker","year":"1996","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.neuropharm.2009.07.025","article-title":"Plasma and brain concentrations of oral therapeutic doses of methylphenidate and their impact on brain monoamine content in mice","volume":"57","author":"Balcioglu","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0022-3565(25)20689-9","article-title":"Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys","volume":"251","author":"Bergman","year":"1989","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00213-008-1093-z","article-title":"Characterization of methylphenidate self-administration and reinstatement in the rat","volume":"199","author":"Botly","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib10","first-page":"111","article-title":"Abuse of medications employed for the treatment of ADHD: results from a large-scale community survey","volume":"10","author":"Bright","year":"2008","journal-title":"Medscape J. Med."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib11","doi-asserted-by":"crossref","first-page":"e749","DOI":"10.1542\/peds.2004-2560","article-title":"Treatment of attention-deficit\/hyperactivity disorder: overview of the evidence","volume":"115","author":"Brown","year":"2005","journal-title":"Pediatrics"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2011.04.015_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neuropharm.2004.07.017","article-title":"Nucleus accumbens cell firing and rapid dopamine signaling during goal-directed behaviors in rats","volume":"47","author":"Carelli","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib13","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1046\/j.1460-9568.1998.00285.x","article-title":"l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA","volume":"10","author":"Cenci","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0006-8993(94)01420-M","article-title":"Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference","volume":"673","author":"Cervo","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib15","first-page":"413","article-title":"The identification and measurement of two new metabolites of naltrexone in human urine","volume":"20","author":"Cone","year":"1978","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2174\/187152706776359646","article-title":"Alcoholism and neuropeptides: an update","volume":"5","author":"Cowen","year":"2006","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.brainres.2006.12.079","article-title":"Effects of early methylphenidate exposure on morphine- and sucrose-reinforced behaviors in adult rats: relationship to dopamine D2 receptors","volume":"1139","author":"Crawford","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/syn.20046","article-title":"Brain kinetics of methylphenidate (Ritalin) enantiomers after oral administration","volume":"53","author":"Ding","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/10550490802019642","article-title":"Characteristics and motives of college students who engage in nonmedical use of methylphenidate","volume":"17","author":"DuPont","year":"2008","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib20","doi-asserted-by":"crossref","first-page":"PL345","DOI":"10.1016\/0024-3205(96)00222-6","article-title":"Place preference and microdialysis studies with two derivatives of methylphenidate","volume":"58","author":"Gatley","year":"1996","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1460-9568.1999.00462.x","article-title":"Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum","volume":"11","author":"Georges","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib22","first-page":"13","article-title":"Treatment of patients with lumbar osteochondrosis by the method of intra-tissular electric stimulation","author":"Gerasimov","year":"1991","journal-title":"Ortop. Travmatol. Protez."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-3565(24)38868-8","article-title":"Comparison between intraperitoneal and oral methylphenidate administration: a microdialysis and locomotor activity study","volume":"295","author":"Gerasimov","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib24","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1097\/00001756-199609020-00011","article-title":"Co-localization of mu opioid receptor is greater with dynorphin than enkephalin in rat striatum","volume":"7","author":"Guttenberg","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib25","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pbb.2008.11.011","article-title":"Methylphenidate potentiates morphine-induced antinociception, hyperthermia, and locomotor activity in young adult rats","volume":"92","author":"Halladay","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib26","article-title":"Methylphenidate treatment in adolescent rats with an attention deficit\/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function","author":"Harvey","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/jpet.108.145813","article-title":"Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors","volume":"329","author":"Hiranita","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib28","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1176\/appi.ajp.2008.08020304","article-title":"Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial","volume":"165","author":"Jayaram-Lindstrom","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib29","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1038\/sj.npp.1301572","article-title":"Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence","volume":"33","author":"Jayaram-Lindstrom","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.jcp.0000144893.29987.e5","article-title":"Effects of naltrexone on the subjective response to amphetamine in healthy volunteers","volume":"24","author":"Jayaram-Lindstrom","year":"2004","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib31","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3565(25)30186-2","article-title":"A\u00a0choice procedure for drug reinforcers: cocaine and methylphenidate in the rhesus monkey","volume":"193","author":"Johanson","year":"1975","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1037\/1064-1297.6.4.367","article-title":"Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate","volume":"6","author":"Kollins","year":"1998","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib33","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1523\/JNEUROSCI.22-16-07264.2002","article-title":"Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine","volume":"22","author":"Kuczenski","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib34","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.biopsych.2004.12.036","article-title":"Stimulant actions in rodents: implications for attention-deficit\/hyperactivity disorder treatment and potential substance abuse","volume":"57","author":"Kuczenski","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib35","first-page":"85","article-title":"Influence of SCH23390 and spiperone on the expression of conditioned place preference induced by d-amphetamine or cocaine in the rat","volume":"41","author":"Liao","year":"1998","journal-title":"Chin. J. Physiol."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1037\/a0019814","article-title":"Methylphenidate as a reinforcer for rats: contingent delivery and intake escalation","volume":"18","author":"Marusich","year":"2010","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1478-7547-3-5","article-title":"A\u00a0review of the economic burden of ADHD","volume":"3","author":"Matza","year":"2005","journal-title":"Cost Eff. Resour. Alloc."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib38","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00004703-200406000-00005","article-title":"The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder","volume":"25","author":"Matza","year":"2004","journal-title":"J.\u00a0Dev. Behav. Pediatr."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1524-4733.2004.71273.x","article-title":"Assessment of health-related quality of life in children: a review of conceptual, methodological, and regulatory issues","volume":"7","author":"Matza","year":"2004","journal-title":"Value Health"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib40","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0079-6123(06)60016-2","article-title":"Co-localization of GABA with other neuroactive substances in the basal ganglia","volume":"160","author":"McGinty","year":"2007","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib41","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0022-3565(24)29412-X","article-title":"Rewarding properties of methylphenidate: sensitization by prior exposure to the drug and effects of dopamine D1- and D2-receptor antagonists","volume":"298","author":"Meririnne","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.2042-7158.1987.tb06254.x","article-title":"Intravenous kinetics and metabolism of [15,16-3H]naltrexonium methiodide in the rat","volume":"39","author":"Misra","year":"1987","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib43","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00181251","article-title":"The effects of haloperidol on amphetamine- and methylphenidate-induced conditioned place preferences and locomotor activity","volume":"90","author":"Mithani","year":"1986","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.brainresbull.2004.03.004","article-title":"The role of D1 and D2 receptors in the cocaine conditioned place preference of male and female rats","volume":"63","author":"Nazarian","year":"2004","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib45","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00004583-200205000-00008","article-title":"National trends in the use of psychotropic medications by children","volume":"41","author":"Olfson","year":"2002","journal-title":"J.\u00a0Am. Acad. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib46","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/jcp.0b013e3181515205","article-title":"Do formulation differences alter abuse liability of methylphenidate? A placebo-controlled, randomized, double-blind, crossover study in recreational drug users","volume":"27","author":"Parasrampuria","year":"2007","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib47","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/(SICI)1099-1077(199711\/12)12:6<527::AID-HUP932>3.0.CO;2-U","article-title":"Pharmacology of methylphenidate, amphetamine enantiomers and pemoline in attention-deficit hyperactivity disorder","volume":"12","author":"Patrick","year":"1997","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib48","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nm0102-24","article-title":"ADHD and addiction","volume":"8","author":"Robbins","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0165-0173(93)90013-P","article-title":"The neural basis of drug craving: an incentive-sensitization theory of addiction","volume":"18","author":"Robinson","year":"1993","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib50","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1098\/rstb.2008.0093","article-title":"Review. The incentive sensitization theory of addiction: some current issues","volume":"363","author":"Robinson","year":"2008","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib51","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1542\/peds.2008-0931","article-title":"Adolescent prescription ADHD medication abuse is rising along with prescriptions for these medications","volume":"124","author":"Setlik","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib52","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0022-3565(25)22808-7","article-title":"Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism","volume":"250","author":"Sivam","year":"1989","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib53","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib54","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.neuroscience.2008.04.063","article-title":"Cocaine reward and hyperactivity in the rat: sites of mu opioid receptor modulation","volume":"154","author":"Soderman","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib55","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1176\/appi.ajp.163.3.387","article-title":"PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate","volume":"163","author":"Spencer","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib56","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.neubiorev.2003.08.013","article-title":"Serum and brain concentrations of methylphenidate: implications for use and abuse","volume":"27","author":"Swanson","year":"2003","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib57","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugalcdep.2009.10.011","article-title":"The endogenous opioid system: a common substrate in drug addiction","volume":"108","author":"Trigo","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib58","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/00952997509005661","article-title":"Naltrexone pharmacology, pharmacokinetics, and metabolism: current status","volume":"2","author":"Verebey","year":"1975","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2011.04.015_bib59","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1177\/070674370200601S05","article-title":"Mechanism of action of methylphenidate: insights from PET imaging studies","volume":"6","author":"Volkow","year":"2002","journal-title":"J.\u00a0Atten. Disord."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib60","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1542\/peds.111.1.179","article-title":"Does stimulant therapy of attention-deficit\/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature","volume":"111","author":"Wilens","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib61","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/npp.2008.188","article-title":"Kappa-opioid system regulates the long-lasting behavioral adaptations induced by early-life exposure to methylphenidate","volume":"34","author":"Wiley","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib62","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0959-4388(96)80079-1","article-title":"Neurobiology of addiction","volume":"6","author":"Wise","year":"1996","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib63","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neulet.2010.10.040","article-title":"Oral methylphenidate establishes a conditioned place preference in rats","volume":"487","author":"Wooters","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib64","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/sj.npp.1301463","article-title":"Acute amphetamine exposure selectively desensitizes [kappa]-opioid receptors in the nucleus accumbens","volume":"33","author":"Xia","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.04.015_bib65","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3565(24)36877-6","article-title":"Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands","volume":"282","author":"Zhu","year":"1997","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib66","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/nm1196-1225","article-title":"Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving","volume":"2","author":"Zubieta","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2011.04.015_bib67","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1176\/appi.ajp.163.4.579","article-title":"Recent trends in stimulant medication use among U.S. children","volume":"163","author":"Zuvekas","year":"2006","journal-title":"Am. J. Psychiatry"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811001602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811001602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T07:42:18Z","timestamp":1741160538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390811001602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":67,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0028390811001602"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.04.015","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}